Sign in
CompletedPhase 1/2

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Key facts

Who runs it
Nacuity Pharmaceuticals, Inc.
Where
Australia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1/2
People taking part
24 people enrolled
Started
27 Jan 2022
Ended
3 Sept 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • NPI-002 Intravitreal Implant
Record updated
9 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Indicated for vitrectomy
  • Natural Lens in place at time of vitrectomy
  • Some cataract present as assessed pre-operatively

Who cannot take part

  • Previous intraocular surgery in study eye
  • Need for oral corticosteroids during study participation
  • Not on stable dose of medications for other conditions
  • Evidence or history of uveitis, or ocular ischemia
  • Evidence or history of proliferative diabetic retinopathy
  • Current lung disease (PU, COPD, Asthma) resulting in decreased oxygen saturation
  • Clear zonular weakness or defects / coloboma
  • Current smoker
  • Use of supplemental oxygen
  • Sensitivity to thiol compounds
  • Participation in another clinical trial

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.

The 3 groups in the trial

  • Single NPI-002 Intravitreal ImplantTreatment being tested

    one NPI-002 implant inserted at the time of vitrectomy

    Treatment: NPI-002 Intravitreal Implant

  • Double NPI-002 Intravitreal ImplantTreatment being tested

    two NPI-002 implants inserted at the time of vitrectomy

    Treatment: NPI-002 Intravitreal Implant

  • ControlNo study treatment, for comparison

    No implant inserted at time of vitrectomy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
Record updated
9 October 2026